Trimitra Prawara Goldland Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Trimitra Prawara Goldland Tbk. trades at Rp555 (market cap 557.5B, 4.54M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 164.65B, 214.9K 24h volume). The key difference: Trimitra Prawara Goldland Tbk. is far larger — about 3.4× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Trimitra Prawara Goldland Tbk. is more actively traded (4.54M versus 214.9K). Which is the better fit depends on your goals.
| ATAP | OBAT | |
|---|---|---|
Market Cap | 557.5B | 164.65B |
Volume | 4.54M | 214.9K |
Lot | 45.39K | 2.15K |
Turnover | 2.47B | 51.97M |
Average Price | 543.8 | 241.85 |
Value | 2.47B | 51.97M |
Indicative Equilibrium Price | 555 | 240 |
Indicative Equilibrium Volume | 104 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Trimitra Prawara Goldland Tbk (the Company) was established in Indonesia based on Notarial Deed No. 13 of Dede Munajat, S.H., on March 23, 2015 a Notary in Bogor. The Company started its commercial operations in 2015.
Read more on ATAP →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →